The alpha-fetoprotein screening test helps predict the occurrence of congenital disease, ... The normal level in non-pregnant adults falls between 0 to 40 ng/mL, ...

To verify the molecular cause of the AFP absence, we analyzed the sequence of all the exons of the Afp and their borders in patient V6 of family A. We identified a deletion of two nucleotides at ...

Alpha-fetoprotein (AFP) is considered to be an indicator of tumor activity in hepatocellular carcinoma (HCC). ... AFP normalization was defined as the reduction of AFP to our institutional normal (≤ ...

Twenty-four of 31 patients showed a decline of > or = 1 log in AFP levels before second surgery (early responders). By the end of treatment, there were 16 patients, all early responders, without ...

However, ultrasound with alpha-fetoprotein significantly increased the sensitivity of HCC detection.“We demonstrated ultrasound has suboptimal sensitivity for early HCC detection, ...

Eureka is currently conducting two clinical trials (ARYA-1 and ARYA-2) in the United States targeting AFP in patients with liver cancer using TCRm antibodies engineered onto ARTEMIS® T cells ...

Among 214,532 women with singleton births, there were 114 cases of SIDS (incidence, 2.7 per 10,000 births among women with alpha-fetoprotein levels in the lowest quintile and 7.5 per 10,000 births ...

GTC BIOTHERAPEUTICS IN-LICENSES RECOMBINANT HUMAN ALPHA-FETOPROTEIN FROM MERRIMACK PHARMACEUTICALS FRAMINGHAM, MA - July 8, 2009 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) has obtained ...

Sept. 1, 2004 — Second-trimester maternal serum alpha-fetoprotein levels are associated with the risk of sudden infant death syndrome (SIDS), according to an analysis of databases published in ...

Firm is looking to partner this drug, which has shown potential in MS and myasthenia. GTC Biotherapeutics obtained exclusive, worldwide rights to recombinant human alpha-fetoprotein (rhAFP) for ...